MX9603999A - Tratamiento de nefropatia diabetica con valsartan. - Google Patents
Tratamiento de nefropatia diabetica con valsartan.Info
- Publication number
- MX9603999A MX9603999A MX9603999A MX9603999A MX9603999A MX 9603999 A MX9603999 A MX 9603999A MX 9603999 A MX9603999 A MX 9603999A MX 9603999 A MX9603999 A MX 9603999A MX 9603999 A MX9603999 A MX 9603999A
- Authority
- MX
- Mexico
- Prior art keywords
- diabetic nephropathy
- treatment
- valsartan
- angiotensin
- antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
El antagonista de angiotensina II de la Formula: (Ver Formula) y las sales farmacéuticamente aceptables del mismo, se pueden utilizar para el tratamiento terapéutico de nefropatía diabética.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH800/94-1 | 1994-03-17 | ||
| CH80094 | 1994-03-17 | ||
| PCT/EP1995/000831 WO1995024901A1 (en) | 1994-03-17 | 1995-03-07 | Treatment of diabetic nephropathy with valsartan |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9603999A true MX9603999A (es) | 1997-12-31 |
| MXPA96003999A MXPA96003999A (es) | 1998-09-18 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| BR9507086A (pt) | 1997-09-16 |
| CN1143908A (zh) | 1997-02-26 |
| CZ268896A3 (en) | 1997-03-12 |
| JPH09510225A (ja) | 1997-10-14 |
| FI963611A0 (fi) | 1996-09-13 |
| HU9602536D0 (en) | 1996-11-28 |
| AU1850695A (en) | 1995-10-03 |
| WO1995024901A1 (en) | 1995-09-21 |
| HUT76542A (en) | 1997-09-29 |
| SK117996A3 (en) | 1997-03-05 |
| CA2184712A1 (en) | 1995-09-21 |
| FI963611A (fi) | 1996-09-13 |
| PL316259A1 (en) | 1997-01-06 |
| EP0750500A1 (en) | 1997-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL144294A0 (en) | P53 inhibitors and therapeutic use of the same | |
| TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
| MY132705A (en) | Novel compounds with analgesic effect | |
| MY110110A (en) | Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders | |
| TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
| CA2263561A1 (en) | Thienopyrimidines | |
| MY115662A (en) | Novel compounds with analgesic effect | |
| PL323825A1 (en) | Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin | |
| GB9514473D0 (en) | Chemical compounds | |
| IS1812B (is) | Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra | |
| AP1806A (en) | The use of a high dosage regimen of amoxycillin and potassium chavulate for the treatment of bacterial infections. | |
| AP2003002755A0 (en) | Guanidinobenzamides as mc4-r agonists | |
| EP1231914A4 (en) | NORDIHYDROGUAIARTIC DERIVATIVES FOR USE IN THE TREATMENT OF TUMORS | |
| IL130083A0 (en) | 3-Pyridyl enantiomers and their use as analgesics | |
| AU9058591A (en) | Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy | |
| TW200508199A (en) | Novel compound | |
| MY121623A (en) | Methods of preventing breast cancer. | |
| GB9108629D0 (en) | Heterocyclic pharmaceutical compounds,preparation and use | |
| NZ512289A (en) | Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases | |
| AU1656997A (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer | |
| MY133169A (en) | Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect | |
| PL371741A1 (en) | A combination treatment for acute myocardial infarction | |
| MX9603999A (es) | Tratamiento de nefropatia diabetica con valsartan. | |
| TW349864B (en) | Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders | |
| MX9701606A (es) | Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno. |